Marksans Pharma has informed that the trading window for dealing in the shares of Marksans Pharma ('the Company') for the designated persons of the Company will remain closed from Saturday, 1st October, 2022 till 48 hours after the declaration of unaudited financial results for the quarter and half-year ended 30th September, 2022. The date of declaration of financial results will be intimated separately in due course of time. Designated Persons of the Company and/or their immediate relatives shall not trade in the shares of the Company during the aforesaid period of closure of trading window.
The above information is a part of company’s filings submitted to BSE.
